Endometrial polyps in female allograft recipients with abnormal bleedings.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4520364)

Published in Prz Menopauzalny on June 30, 2014

Authors

Dariusz Rajski1, Katarzyna Bobrowska1, Bronisława Pietrzak1, Mirosław Wielgoś1, Paweł Kamiński1

Author Affiliations

1: I Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.

Articles cited by this

Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99

Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77

Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol (2004) 2.01

Cancer risk in patients on dialysis and after renal transplantation. Lancet (2000) 1.87

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. J Invest Dermatol (2005) 1.86

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation (2004) 1.68

Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer (1986) 1.58

Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause (2011) 1.54

Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril (2008) 1.51

Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45

Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet (1986) 1.06

Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography and hysteroscopy. J Obstet Gynaecol (2011) 1.06

Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant (1994) 1.02

The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Pathol Lab Med (2007) 0.97

HPV infections and immunosuppression. Clin Dermatol (1997) 0.95

Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. J Minim Invasive Gynecol (2010) 0.93

Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients. Am J Transplant (2008) 0.92

Premalignant and malignant uterine changes in immunosuppressed renal transplant recipients. Acta Obstet Gynecol Scand (1978) 0.90

Role of hysteroscopy in the detection of endometrial pathologies in women presenting with postmenopausal bleeding and thickened endometrium. Arch Gynecol Obstet (2011) 0.88

Endometrial polyp size and polyp hyperplasia. Int J Gynaecol Obstet (2013) 0.88

Steroid hormone receptor profile of premenopausal endometrial polyps. Reprod Sci (2010) 0.88

Gynecological and reproductive function after liver transplantation. Transplantation (1996) 0.81

Gynecological issues after organ transplantation. Neuro Endocrinol Lett (2008) 0.79

Three-dimensional sonohysterography may replace hysteroscopy for women with perimenopausal bleeding. Climacteric (2013) 0.78

Normalization of menstrual pattern after liver transplantation: consequences for contraception. Digestion (1990) 0.78

ACE inhibitors and angiotensin receptor blockers could promote the onset of endometrial polyps in hypertensive women. Int J Clin Pharmacol Ther (2013) 0.78

Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Anal Quant Cytol Histol (2011) 0.77